United by an ambitious goal: The members of the Alliance to Zero are committed to sustainably reducing CO₂ emissions along the pharmaceutical supply chain—with a view toward compliance with the Paris Climate Agreement. Halfway into the year, the network got together for an onsite meeting at Schreiner MediPharm in Oberschleissheim—engaged in an intensive exchange with a vision.

The Alliance has existed since June 2021. In addition to the founding members—Datwyler, Harro Höfliger, Körber Pharma, SCHOTT Pharma, Sharp, Ypsomed, and Schreiner MediPharm—Resourcify, a specialist in recycling solutions, has now also joined the initiative. All members share a common goal: Only through close collab­oration can changes be achieved that will transform the entire sector toward net-zero emissions. A specific example of successful collaboration is a Secure Blister-Free Packaging Concept for prefilled syringes that considerably reduces CO₂ emissions, optimizes processes, and reduces costs at the same time.

The most recent meeting in Oberschleissheim offered the Alliance an opportunity to continue driving important topics. In addition to technical presentations—for instance, on the pending Packaging and Packaging Waste Regulation (PPWR)—specific actions were developed in strategic discussions and special working groups.

Company Tour as a Highlight

The company tour at Schreiner Group’s headquarters in Oberschleissheim was a highlight of the gathering. It provided the guests with deep insights into the high-tech production of innovative pharma labels and enabled them to obtain an on-site idea of Schreiner Group’s sustainability measures. A joint evening event rounded off the day and provided room for further informal exchange—all in the spirit of trusting col­laboration on which the Alliance to Zero is based.